<code id='CDCFE9B8C1'></code><style id='CDCFE9B8C1'></style>
    • <acronym id='CDCFE9B8C1'></acronym>
      <center id='CDCFE9B8C1'><center id='CDCFE9B8C1'><tfoot id='CDCFE9B8C1'></tfoot></center><abbr id='CDCFE9B8C1'><dir id='CDCFE9B8C1'><tfoot id='CDCFE9B8C1'></tfoot><noframes id='CDCFE9B8C1'>

    • <optgroup id='CDCFE9B8C1'><strike id='CDCFE9B8C1'><sup id='CDCFE9B8C1'></sup></strike><code id='CDCFE9B8C1'></code></optgroup>
        1. <b id='CDCFE9B8C1'><label id='CDCFE9B8C1'><select id='CDCFE9B8C1'><dt id='CDCFE9B8C1'><span id='CDCFE9B8C1'></span></dt></select></label></b><u id='CDCFE9B8C1'></u>
          <i id='CDCFE9B8C1'><strike id='CDCFE9B8C1'><tt id='CDCFE9B8C1'><pre id='CDCFE9B8C1'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:44258
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          European officials brace for rough respiratory virus season
          European officials brace for rough respiratory virus season

          FinnbarrWebster/GettyImagesLONDON—HealthofficialsintheU.K.andEuropearerampinguptheircampaignsurginge

          read more
          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more

          The United States is paying nearly triple for new Covid vaccines

          HealthsecretaryXavierBecerrareceivesanupdatedCovid-19boosterinSeptember.DrewAngerer/GettyImagesWASHI